EMERGENT BIOSOLUTIONS INC. Property, Plant and Equipment, Gross
EMERGENT BIOSOLUTIONS INC. (EBS) had Property, Plant and Equipment, Gross of $475.10 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-06
- 2026-06-30: Property, Plant and Equipment, Gross $475.10M.
- 2026-03-31: Property, Plant and Equipment, Gross $509.40M.
- 2025-12-31: Property, Plant and Equipment, Gross $509.50M.
- 2025-09-30: Property, Plant and Equipment, Gross $500.50M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-06-30 | $475.10M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $509.40M 10-Q · filed 2026-05-01 | |
| 2025-12-31 | $509.50M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $500.50M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $515.70M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $517.80M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $667.70M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $671.90M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $706.90M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $802.00M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $794.20M 10-K · filed 2025-03-04 | |
| 2023-09-30 | $796.30M 10-Q · filed 2023-12-11 | |
| 2023-06-30 | $786.90M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $1.09B 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $1.20B 10-K · filed 2024-03-08 | |
| 2022-09-30 | $1.17B 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $1.16B 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $1.14B 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $1.12B 10-K/A · filed 2023-12-11 | |
| 2021-09-30 | $1.07B 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $1.03B 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $964.40M 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $903.20M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $853.40M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $814.50M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $771.00M 10-Q · filed 2020-05-01 | |
| 2019-12-31 | $752.70M 10-K · filed 2021-02-19 | |
| 2019-09-30 | $729.10M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $709.70M 10-Q · filed 2019-08-02 | |
| 2019-03-31 | $697.20M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $681.70M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $595.46M 10-Q · filed 2018-11-02 | |
| 2018-06-30 | $571.73M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $556.01M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $539.60M 10-K · filed 2019-02-22 | $539.58M 10-K · filed 2018-02-23 |
| 2017-09-30 | $519.72M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $507.62M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $501.07M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $488.00M 10-K · filed 2018-02-23 | |
| 2016-09-30 | $470.87M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $469.16M 10-Q · filed 2016-08-05 | |
| 2015-12-31 | $421.57M 10-K · filed 2017-02-28 | $431.38M 10-K · filed 2016-02-29 |
| 2014-12-31 | $393.41M 10-K · filed 2016-02-29 | |
| 2013-12-31 | $321.61M 10-K · filed 2015-03-09 | |
| 2012-12-31 | $284.71M 10-K · filed 2014-03-10 | |
| 2011-12-31 | $241.43M 10-K · filed 2013-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |